Showing results (291-300 of 311) with videos related to
Sort By:
Pageof 32
Journal of the National Cancer Institute|March 17, 2018
Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP StudyGary R Zirpoli, Susan E McCann, Lara E Sucheston-Campbell, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Selective PPARgamma modulators with improved pharmacological profilesKun Liu, Regina M Black, John J Acton, et al.Breast Cancer Research : BCR|November 30, 2018
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)Jennifer M Mongiovi, Gary R Zirpoli, Rikki Cannioto, et al.Journal of Medicinal Chemistry|June 11, 2009
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volumeJohn J Acton, Taro E Akiyama, Ching H Chang, et al.Anesthesia and Analgesia|May 11, 2017
Differences in Blood Pressure in Infants After General Anesthesia Compared to Awake Regional Anesthesia (GAS Study-A Prospective Randomized Trial)M E McCann, D E Withington, S J Arnup, et al.Journal of Medicinal Chemistry|January 7, 2005
(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetesDooseop Kim, Liping Wang, Maria Beconi, et al.Journal of the National Cancer Institute|April 3, 2020
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With SurvivalRikki A Cannioto, Alan Hutson, Shruti Dighe, et al.Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole coreDong-Ming Shen, Edward J Brady, Mari R Candelore, et al.Genome Research|October 10, 2001
Chromosome-specific single-locus FISH probes allow anchorage of an 1800-marker integrated radiation-hybrid/linkage map of the domestic dog genome to all chromosomesM Breen, S Jouquand, C Renier, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2005
Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonistsDong-Ming Shen, Fengqi Zhang, Edward J Brady, et al.Pageof 32